FDA premarket cybersecurity guidance clarifies SBOM requirements
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesCombination products/companion diagnosticsComplianceDiagnostics/IVDsDigital health/SaMD/AIMedical DevicesNorth AmericaPharmaceuticalsProduct LifecycleRegulatory Intelligence/PolicyResearch, Design and DevelopmentRisk managementUnited States